tosufloxacin has been researched along with Empyema, Gall Bladder in 1 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "T-3262 (tosufloxacin tosilate), a new oral pyridone carboxylic acid agent, was investigated for its biliary excretion and clinical efficacy and safety to evaluate its usefulness in the treatment of cholecystitis." | 7.67 | [Biliary excretion and clinical efficacy of T-3262 (tosufloxacin tosilate) administered in the treatment of cholecystitis]. ( Iwamura, K; Kato, Y; Ohguri, S; Okabe, K; Shibata, H; Sugata, F; Takamura, Y; Tominaga, S; Yamada, N; Yamada, T, 1989) |
| "T-3262 (tosufloxacin tosilate), a new oral pyridone carboxylic acid agent, was investigated for its biliary excretion and clinical efficacy and safety to evaluate its usefulness in the treatment of cholecystitis." | 3.67 | [Biliary excretion and clinical efficacy of T-3262 (tosufloxacin tosilate) administered in the treatment of cholecystitis]. ( Iwamura, K; Kato, Y; Ohguri, S; Okabe, K; Shibata, H; Sugata, F; Takamura, Y; Tominaga, S; Yamada, N; Yamada, T, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugata, F | 1 |
| Ohguri, S | 1 |
| Takamura, Y | 1 |
| Tominaga, S | 1 |
| Iwamura, K | 1 |
| Yamada, T | 1 |
| Shibata, H | 1 |
| Yamada, N | 1 |
| Okabe, K | 1 |
| Kato, Y | 1 |
1 other study available for tosufloxacin and Empyema, Gall Bladder
| Article | Year |
|---|---|
[Biliary excretion and clinical efficacy of T-3262 (tosufloxacin tosilate) administered in the treatment of cholecystitis].
Topics: 4-Quinolones; Adult; Aged; Anti-Infective Agents; Bile; Cholecystitis; Drug Evaluation; Female; Fluo | 1989 |